Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Mus musculus | CD22 antigen | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.0042 | 0.0018 | 0.0169 |
Plasmodium vivax | beta-ketoacyl-acyl carrier protein synthase III precursor, putative | 0.0687 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0042 | 0.0018 | 0.0408 |
Echinococcus multilocularis | ubiquitin conjugating enzyme E2 N | 0.0045 | 0.0055 | 0.0228 |
Loa Loa (eye worm) | beta-LACTamase domain containing family member | 0.0042 | 0.0018 | 0.0408 |
Loa Loa (eye worm) | beta-lactamase | 0.0042 | 0.0018 | 0.0408 |
Echinococcus granulosus | jumonji domain containing protein | 0.0047 | 0.0095 | 0.0394 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0089 | 0.0746 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0042 | 0.0018 | 0.0408 |
Plasmodium vivax | ubiquitin-conjugating enzyme E2 N, putative | 0.0045 | 0.0055 | 0.0037 |
Brugia malayi | jmjC domain containing protein | 0.0111 | 0.1083 | 1 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0042 | 0.0015 | 0.0138 |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.0687 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0042 | 0.0018 | 0.0408 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.027 | 0.3537 | 0.3525 |
Echinococcus granulosus | beta LACTamase domain containing family member | 0.0042 | 0.0018 | 0.0076 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.0264 | 0.5899 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.0687 | 1 | 1 |
Schistosoma mansoni | jumonji domain containing protein | 0.0088 | 0.073 | 0.3024 |
Schistosoma mansoni | ubiquitin conjugating enzyme 13 | 0.0045 | 0.0055 | 0.0228 |
Trypanosoma brucei | ubiquitin-protein ligase, putative | 0.0045 | 0.0055 | 1 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0042 | 0.0018 | 0.0076 |
Brugia malayi | beta-lactamase | 0.0042 | 0.0018 | 0.0169 |
Brugia malayi | Ubiquitin conjugating enzyme protein 13 | 0.0045 | 0.0055 | 0.0507 |
Toxoplasma gondii | ubiquitin-conjugating enzyme subfamily protein | 0.0045 | 0.0055 | 1 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.0687 | 1 | 1 |
Trypanosoma cruzi | ubiquitin-conjugating enzyme E2, putative | 0.0045 | 0.0055 | 1 |
Mycobacterium leprae | conserved hypothetical protein | 0.0042 | 0.0018 | 0.5 |
Mycobacterium ulcerans | beta-ketoacyl synthase-like protein | 0.0687 | 1 | 1 |
Echinococcus granulosus | Transcription factor JmjC domain containing protein | 0.0111 | 0.1083 | 0.4487 |
Echinococcus granulosus | geminin | 0.0197 | 0.2413 | 1 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.007 | 0.0448 | 1 |
Brugia malayi | beta-lactamase family protein | 0.0042 | 0.0018 | 0.0169 |
Echinococcus multilocularis | Transcription factor, JmjC domain containing protein | 0.0111 | 0.1083 | 0.4487 |
Loa Loa (eye worm) | ubiquitin conjugating enzyme protein 13 | 0.0045 | 0.0055 | 0.1226 |
Echinococcus multilocularis | geminin | 0.0197 | 0.2413 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0042 | 0.0018 | 0.0408 |
Loa Loa (eye worm) | immunoglobulin I-set domain-containing protein | 0.0042 | 0.0015 | 0.0333 |
Schistosoma mansoni | hypothetical protein | 0.0197 | 0.2413 | 1 |
Echinococcus multilocularis | jumonji domain containing protein | 0.0047 | 0.0095 | 0.0394 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0042 | 0.0018 | 0.0076 |
Schistosoma mansoni | hypothetical protein | 0.0197 | 0.2413 | 1 |
Brugia malayi | ubiquitin conjugating enzyme protein 13 | 0.0045 | 0.0055 | 0.0507 |
Trypanosoma cruzi | ubiquitin-conjugating enzyme E2, putative | 0.0045 | 0.0055 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0089 | 0.0746 | 1 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0042 | 0.0015 | 0.0138 |
Plasmodium falciparum | beta-ketoacyl-ACP synthase III | 0.0687 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0042 | 0.0018 | 0.0408 |
Echinococcus multilocularis | beta LACTamase domain containing family member | 0.0042 | 0.0018 | 0.0076 |
Onchocerca volvulus | 0.0042 | 0.0018 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0042 | 0.0018 | 0.0408 |
Mycobacterium leprae | Probable lipase LipE | 0.0042 | 0.0018 | 0.5 |
Leishmania major | ubiquitin-conjugating enzyme e2, putative | 0.0045 | 0.0055 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0089 | 0.0746 | 1 |
Onchocerca volvulus | 0.0042 | 0.0018 | 0.5 | |
Onchocerca volvulus | 0.0042 | 0.0018 | 0.5 | |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) | 0.0687 | 1 | 1 |
Loa Loa (eye worm) | immunoglobulin I-set domain-containing protein | 0.0042 | 0.0015 | 0.0333 |
Loa Loa (eye worm) | ubiquitin conjugating enzyme protein 13 | 0.0045 | 0.0055 | 0.1226 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0089 | 0.0746 | 1 |
Brugia malayi | beta-lactamase family protein | 0.0042 | 0.0018 | 0.0169 |
Trichomonas vaginalis | ubiquitin-conjugating enzyme E2, putative | 0.0045 | 0.0055 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0089 | 0.0746 | 1 |
Echinococcus granulosus | ubiquitin conjugating enzyme E2 N | 0.0045 | 0.0055 | 0.0228 |
Trichomonas vaginalis | ubiquitin-conjugating enzyme E2, putative | 0.0045 | 0.0055 | 1 |
Brugia malayi | hypothetical protein | 0.0068 | 0.0425 | 0.3929 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.1 uM | Binding affinity to mouse CD22 after 1 hr by competition ELISA | ChEMBL. | 19720531 |
Ratio IC50 (binding) | = 38.4 | Ratio of 9-(40-hydroxy-4-biphenyl)acetamido-9-deoxy- Neu5Gca2-6GalOMP IC50 to compound IC50 for mouse CD22 after 1 hr by competition ELISA | ChEMBL. | 19720531 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.